Androgenic Alopecia
Mostrando 1-6 de 6 artigos, teses e dissertações.
-
1. Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients
Abstract Background Androgenetic alopecia in the pediatric population is rarely discussed in the literature. Although the prevalence of the metabolic syndrome is increased in patients with early-onset androgenetic alopecia, the presence of metabolic syndrome risk factors in pediatric androgenetic alopecia is unknown. Objective To evaluate the demographics,
Anais Brasileiros de Dermatologia. Publicado em: 2022
-
2. Post-finasteride syndrome,
Abstract Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there have been reports of adverse drug-related reactions that persisted for at least three months after disc
An. Bras. Dermatol.. Publicado em: 2020-06
-
3. Stress e raiva em mulheres com alopecia androgenÃtica / Stress and anger in women with androgenic alopecia
A Alopecia AndrogenÃtica (AA) Ã caracterizada pela perda e afinamento progressivo dos cabelos e, pode surgir em qualquer idade. Ã identificada como um quadro geneticamente determinado com a participaÃÃo dos hormÃnios esterÃides andrÃgenos. O objetivo desse estudo foi verificar a existÃncia de possÃveis associaÃÃes entre o stress e o sentimento de
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 24/02/2012
-
4. Effect of petroleum ether and ethanol fractions of seeds of Abrus precatorius on androgenic alopecia
Seeds of Abrus precatorius L., Fabaceae, are commonly used as purgative, emetic, aphrodisiac and in nervous disorder in traditional and folk medicines. In present study petroleum ether and ethanolic extracts of A. precatorius seeds are evaluated for reversal of androgen (testosterone by i.m route) induced alopecia in male albino wistar rats and compared to t
Revista Brasileira de Farmacognosia. Publicado em: 05/12/2011
-
5. Desenvolvimento de sistemas de liberação para a administração tópica passiva e iontoforética do minoxidil no tratamento da alopecia androgênica / Development of delivery systems for the topical passive and iontophoretic administration of minoxidil for the androgenic alopecia treatment
Given the hypothesis that polymeric microparticles can penetrate the skin barrier along the transfollicular route, and based on the evidence that iontophoresis is a method that can direct the delivery of drugs to the hair follicles, this work aimed to study the in vitro skin permeation of minoxidil sulfate (MXS), a drug used to treat androgenic alopecia, bot
Publicado em: 2009
-
6. Análise da frequência de polimorfismos no gene LHB e parâmetros clínicos em portadoras de síndrome de ovários policísticos
Introduction: The polycystic ovary syndrome (PCOS) is an endocrinopaty characterized by chronic, discontinuous anovulation and excess of androgens, which leads to oligo or amenorrhea, hirsutism, acne and androgenic alopecia. There are many theories to explain the phisiopatogenics of the PCOS, and it is also related to the metabolic syndrome. Recent findings
Publicado em: 2009